These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Kaolin-induced chronic hydrocephalus accelerates amyloid deposition and vascular disease in transgenic rats expressing high levels of human APP. Silverberg GD; Miller MC; Pascale CL; Caralopoulos IN; Agca Y; Agca C; Stopa EG Fluids Barriers CNS; 2015; 12(1):2. PubMed ID: 25685319 [TBL] [Abstract][Full Text] [Related]
23. Origins of Beta Amyloid Differ Between Vascular Amyloid Deposition and Parenchymal Amyloid Plaques in the Spinal Cord of a Mouse Model of Alzheimer's Disease. Yuan Q; Liu X; Xian YF; Tang Y; Zou J; Zhang X; Huang P; Wu W; Song YQ; Lin ZX Mol Neurobiol; 2020 Jan; 57(1):278-289. PubMed ID: 31325023 [TBL] [Abstract][Full Text] [Related]
24. TGF-β1 protection against Aβ1-42-induced hippocampal neuronal inflammation and apoptosis by TβR-I. Fang XX; Sun GL; Zhou Y; Qiu YH; Peng YP Neuroreport; 2018 Jan; 29(2):141-146. PubMed ID: 29200096 [TBL] [Abstract][Full Text] [Related]
25. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models. Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230 [TBL] [Abstract][Full Text] [Related]
26. Amyloid-β (Aβ) immunotherapy induced microhemorrhages are associated with activated perivascular macrophages and peripheral monocyte recruitment in Alzheimer's disease mice. Taylor X; Clark IM; Fitzgerald GJ; Oluoch H; Hole JT; DeMattos RB; Wang Y; Pan F Mol Neurodegener; 2023 Aug; 18(1):59. PubMed ID: 37649100 [TBL] [Abstract][Full Text] [Related]
27. Metformin attenuates vascular pathology by increasing expression of insulin-degrading enzyme in a mixed model of cerebral amyloid angiopathy and type 2 diabetes mellitus. Inoue Y; Masuda T; Misumi Y; Ando Y; Ueda M Neurosci Lett; 2021 Sep; 762():136136. PubMed ID: 34311050 [TBL] [Abstract][Full Text] [Related]
28. Viral-induced inflammation is accompanied by beta-amyloid plaque reduction in brains of amyloid precursor protein transgenic Tg2576 mice. Stahl T; Reimers C; Johne R; Schliebs R; Seeger J Eur J Neurosci; 2006 Oct; 24(7):1923-34. PubMed ID: 17067295 [TBL] [Abstract][Full Text] [Related]
29. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons. Van Dorpe J; Smeijers L; Dewachter I; Nuyens D; Spittaels K; Van Den Haute C; Mercken M; Moechars D; Laenen I; Kuiperi C; Bruynseels K; Tesseur I; Loos R; Vanderstichele H; Checler F; Sciot R; Van Leuven F Am J Pathol; 2000 Oct; 157(4):1283-98. PubMed ID: 11021833 [TBL] [Abstract][Full Text] [Related]
30. Fruquintinib/HMPL-013 ameliorates cognitive impairments and pathology in a mouse model of cerebral amyloid angiopathy (CAA). Zhou G; Xiang T; Xu Y; He B; Wu L; Zhu G; Xie J; Yao L; Xiao Z Eur J Pharmacol; 2023 Jan; 939():175446. PubMed ID: 36470443 [TBL] [Abstract][Full Text] [Related]
35. UV light-induced autofluorescence of full-length Abeta-protein deposits in the human brain. Thal DR; Ghebremedhin E; Haass C; Schultz C Clin Neuropathol; 2002; 21(1):35-40. PubMed ID: 11846043 [TBL] [Abstract][Full Text] [Related]
36. Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease. Guzmán EA; Bouter Y; Richard BC; Lannfelt L; Ingelsson M; Paetau A; Verkkoniemi-Ahola A; Wirths O; Bayer TA Mol Neurodegener; 2014 Apr; 9():13. PubMed ID: 24694184 [TBL] [Abstract][Full Text] [Related]
37. Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation. Kulic L; McAfoose J; Welt T; Tackenberg C; Späni C; Wirth F; Finder V; Konietzko U; Giese M; Eckert A; Noriaki K; Shimizu T; Murakami K; Irie K; Rasool S; Glabe C; Hock C; Nitsch RM Transl Psychiatry; 2012 Nov; 2(11):e183. PubMed ID: 23149447 [TBL] [Abstract][Full Text] [Related]
38. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease. Wyss-Coray T; Masliah E; Mallory M; McConlogue L; Johnson-Wood K; Lin C; Mucke L Nature; 1997 Oct; 389(6651):603-6. PubMed ID: 9335500 [TBL] [Abstract][Full Text] [Related]
39. Cerebrovascular pathology during the progression of experimental Alzheimer's disease. Giannoni P; Arango-Lievano M; Neves ID; Rousset MC; Baranger K; Rivera S; Jeanneteau F; Claeysen S; Marchi N Neurobiol Dis; 2016 Apr; 88():107-17. PubMed ID: 26774030 [TBL] [Abstract][Full Text] [Related]
40. Protection of TGF-β1 against neuroinflammation and neurodegeneration in Aβ1-42-induced Alzheimer's disease model rats. Chen JH; Ke KF; Lu JH; Qiu YH; Peng YP PLoS One; 2015; 10(2):e0116549. PubMed ID: 25658940 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]